Report Type
Single Stock Research Reports
Recent single stock reports highlight a recurring theme of solid top-line performance paired with aggressive strategic reinvestment, though varied operational headwinds are impacting near-term profitability across sectors. Veralto and Fluence Energy reported revenue largely in line with expectations, yet experienced contrasting margin outcomes; Veralto achieved a 24.6% operating margin beat, while Fluence's gross margins were compressed to 5.6% due to project-specific cost overruns. In the technology space, Alphabet’s massive AI build-out is reflected in 2026 Capex guidance of $175-185 billion, a shift that is forcing analysts to abandon free cash flow yield in favor of P/E and EBITDA valuation frameworks. Growth outlooks remain cautious, with Match Group signaling softer 2026 revenue due to regulatory costs and Veralto projecting moderate sales growth between LSD+ and MSD+. Macroeconomic risks are also tempering sentiment, as evidenced by downgrades for Harbour Energy driven by anticipated 2026 LNG oversupply and high leverage. Collectively, these reports underscore a market environment where robust demand and backlogs, such as Fluence’s $5.5 billion, must be weighed against rising capital intensity and shifting valuation metrics.
527 reports available
All reports
Page 6 of 22
Raise Estimates and Price Target on Ferrovial SE
Goldman Sachs · May 28, 2026
Feedback From Dbaccess European Champions Conference
Deutsche Bank · May 28, 2026
Wagners: Favorable Industry Dynamics Supporting Growth
Goldman Sachs · May 28, 2026
ENHANCE Phase 3 Validates Single-Dose Regimen
Goldman Sachs · May 28, 2026
Lead Intelligent Upgrade to Buy
Goldman Sachs · May 28, 2026
Banco Macro 1Q26 First Take: Stronger Revenues Offset Higher Provisions
Goldman Sachs · May 28, 2026
Heico Corp. F2Q26 First Take: Sizable Beat
Goldman Sachs · May 28, 2026
Quantifying Fiber Impacts and Updating Numbers Post 1Q26
Goldman Sachs · May 28, 2026
PDD Holdings 1Q26 Review A Step Closer to Costco Disney Vision
Goldman Sachs · May 28, 2026
Topsports International Holdings 2HFY26 Results First Take
Goldman Sachs · May 28, 2026
Pfizer Sig Vedotin Trial Protocol Amendment
Goldman Sachs · May 28, 2026
Lowering Estimates and Target Price for freee K.K.
Goldman Sachs · May 26, 2026
ACM Research Enhanced Tools Riding on Advanced Logic and Memory Expansion
Goldman Sachs · May 26, 2026
Mitsui E&S Rolling Medium Term Plan Update
Goldman Sachs · May 26, 2026
Femsa Model Update Post Q1
Goldman Sachs · May 26, 2026
Takeaways from NDR with Management
Goldman Sachs · May 26, 2026
PAT Beat and Strong Execution
Goldman Sachs · May 26, 2026
Hospital Hardware and Gross Margin Outperformance with Reassuring FY27 Guidance
Goldman Sachs · May 26, 2026
Guzman y Gomez Data Update
Goldman Sachs · May 26, 2026
Conference Call: Order Momentum Could Accelerate in FY6/27 Centered on ACTIS
Goldman Sachs · May 26, 2026
Otsuka Corporation Update
Goldman Sachs · May 26, 2026
Booz Allen Hamilton: A Lower Bar
Goldman Sachs · May 26, 2026
Eisai's 3-Year Leqembi Outlook Implies In Line Royalties
Goldman Sachs · May 26, 2026
Fubon Financial Holdings 1Q26 Results Briefing Takeaways
Goldman Sachs · May 26, 2026